A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.
Saved in:
| Title: | A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice. |
|---|---|
| Authors: | De Angelis, Maria Laura1 (AUTHOR), Francescangeli, Federica1 (AUTHOR), Aricò, Eleonora1 (AUTHOR), Verachi, Paola1 (AUTHOR), Zucchetti, Massimo2 (AUTHOR), Matteo, Cristina2 (AUTHOR), Petricci, Elena3 (AUTHOR), Pilozzi, Emanuela4 (AUTHOR), Orienti, Isabella5 (AUTHOR), Boe, Alessandra6 (AUTHOR), Eramo, Adriana1 (AUTHOR), Rossi, Rachele1 (AUTHOR), Corati, Tiberio4 (AUTHOR), Macchia, Daniele7 (AUTHOR), Pacca, Anna Maria7 (AUTHOR), Zeuner, Ann1 (AUTHOR) ann.zeuner@iss.it, Baiocchi, Marta1 (AUTHOR) marta.baiocchi@iss.it |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 11/5/2024, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
